GlassScriptPhysician profile
Nathan H Kander
NPI 1073518940
$15,669.26
in general payments reported to CMS, 2019-2025
18 companies · $1,102 in 2025
The $1,102 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,758 · 2020: $1,122 · 2021: $1,798 · 2022: $2,219 · 2023: $2,206 · 2024: $1,464 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,663 · Education: $79.99 · Travel and Lodging: $29.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,662.83 |
| Education | $79.99 |
| Travel and Lodging | $29.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,390.82 | 2021-2025 | Orsiro Mission, Pantera Leo, Nhancer Rx |
| Abbott Laboratories | $3,166.89 | 2019-2025 | Mitraclip, Portico, Xience Skypoint |
| Livanova USA, INC. | $2,697.42 | 2019 | |
| Medtronic Vascular, INC. | $1,576.95 | 2019 | |
| Boston Scientific Corporation | $1,316.91 | 2019-2025 | Avvigo Guidance System, Opticross |
| Edwards Lifesciences Corporation | $1,089.20 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $431.12 | 2021-2023 | Corevalve Evolut R, Cg Future |
| Zoll Circulation INC | $394.21 | 2020-2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Astrazeneca Pharmaceuticals LP | $354.70 | 2022-2023 | Brilinta |
| Shockwave Medical, INC | $354.68 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $213.49 | 2019-2020 | |
| Teleflex LLC | $174.15 | 2024 | Turnpike |
| Janssen Pharmaceuticals, INC | $153.71 | 2021 | |
| Abiomed | $142.08 | 2025 | |
| Itamar Medical INC | $117.87 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $62.67 | 2019 | |
| Pfizer INC. | $19.80 | 2024 | |
| Siemens Medical Solutions USA, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Kander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.